Notice Type
Departmental
Notice Title

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Cocois
Active Ingredient(s): Coal tar (solution) 120mg/g
Salicylic acid 20mg/g
Sulphur 40mg/g
Dosage Form: Topical ointment
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer(s): Bioglan AB, Malmo, Sweden
Product: Duro-Tuss Junior
Active Ingredient(s): Pholcodine 1mg/mL
Dosage Form: Linctus
New Zealand Sponsor: 3M Pharmaceuticals - a division of 3M New Zealand Limited
Manufacturer(s): 3M Pharmaceuticals (Australia) Pty Limited, Thornleigh, New South Wales, Australia
Product: Enalapril
Active Ingredient(s): Enalapril maleate 10mg
Dosage Form: Tablet
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturer(s): Delta Limited, Hafnarfjordur, Iceland
Product: Enalapril
Active Ingredient(s): Enalapril maleate 2.5mg
Dosage Form: Tablet
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturer(s): Delta Limited, Hafnarfjordur, Iceland
Product: Enalapril
Active Ingredient(s): Enalapril maleate 20mg
Dosage Form: Tablet
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturer(s): Delta Limited, Hafnarfjordur, Iceland
Product: Enalapril
Active Ingredient(s): Enalapril maleate 5mg
Dosage Form: Tablet
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturer(s): Delta Limited, Hafnarfjordur, Iceland
Product: NovoMix 30 NovoLet
Active Ingredient(s): Insulin aspart 100IU/mL
Dosage Form: Suspension for injection
New Zealand Sponsor: Novo Nordisk Pharmaceuticals Limited
Manufacturer(s): Novo Nordisk A/S, Bagsvaerd, Copenhagen, Denmark
Product: NovoMix 30 Penfill
Active Ingredient(s): Insulin aspart 100IU/mL
Dosage Form: Suspension for injection
New Zealand Sponsor: Novo Nordisk Pharmaceuticals Limited
Manufacturer(s): Novo Nordisk A/S, Bagsvaerd, Copenhagen, Denmark
Product: Omnicare 1 Step Starter Pack (Combination Product)
Active Ingredient(s): Sodium chloride 0.85%w/v
Dosage Form: Lens Plus Purite Contact lens solution
Active Ingredient(s): Miranol (imidazoline derivative) 1.5%w/v
Ninol 1%w/v
Sodium tridecyl ether (3) sulphate 1.5%w/v
Dosage Form: Omnicare Daily Cleaner Contact lens solution
Active Ingredient(s): Hydrogen peroxide 3.1%w/v
Dosage Form: Omnicare Disinfecting Solution Contact lens solution
Active Ingredient(s): Catalase 0.1mg
Dosage Form: Omnicare Neutralising 1 Step Tablet for contact lens solution
Active Ingredient(s): Subtilisin 0.4mg
Dosage Form: Ultrazyme Protein Remover Tablet for contact lens solution
Manufacturer(s): Allergan Pharmaceuticals (Ireland) Limited, Westport, County Mayo, Ireland
New Zealand Sponsor: Allergan New Zealand Limited
Product: Zostrix HP
Active Ingredient(s): Capsaicin 0.075%w/w
Dosage Form: Topical cream
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer(s): Pharmasol Limited, Andover, Hampshire, United Kingdom
Dated this 6th day of June 2001.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).